Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Gene Therapy Clinical Trials 2015 NCI 5R01CA077544-14 Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine DIAMOND, DON CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $533,838
Gene Therapy Clinical Trials 2015 NCI 5R01CA165206-04 CD19 Directed CAR Therapy JUNE, CARL UNIVERSITY OF PENNSYLVANIA PA $504,482
Gene Therapy Clinical Trials 2015 NCI 5P30CA006516-50 6093 Vector MULLIGAN, RICHARD HARVARD MEDICAL SCHOOL MA $240,341
Gene Therapy Clinical Trials 2015 NCI 5K23CA154874-03 Optimization of adoptive immunotherapy with autologous CD20-specific T cells TILL, BRIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $171,720
Gene Therapy Clinical Trials 2015 NIDDK 5R01DK095169-03 Gene Transfer for Galactosialidosis - Resub NIENHUIS, ARTHUR ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $711,009
Gene Therapy Clinical Trials 2015 NHLBI 1U01HL121842-01A1 Phase II Study of AAV9-GAA Gene Transfer in Pompe Disease BYRNE, BARRY UNIVERSITY OF FLORIDA FL $682,078
Gene Therapy Clinical Trials 2015 NEI 5U10EY023558-02 Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial GUY, JOHN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $2,050,445
Gene Therapy Clinical Trials 2015 NEI 5U10EY024247-02 Biostatistics Center for Leber's Hereditary Optic Neuropathy: Gene Therapy Trial FEUER, WILLIAM UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $116,387
Gene Therapy Clinical Trials 2015 NIAID 5K23AI114381-02 Diversity of Immune Responses Elicited by HIV Vaccines STEPHENSON, KATHRYN BETH ISRAEL DEACONESS MEDICAL CENTER MA $145,636
Gene Therapy Clinical Trials 2015 NCI 5P30CA006973-52 5841 CELL PROCESSING AND GENE THERAPY JAFFEE, ELIZABETH JOHNS HOPKINS UNIVERSITY MD $419,512
Gene Therapy Clinical Trials 2015 NHLBI 5U10HL108945-05 Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $160,218
Gene Therapy Clinical Trials 2015 NCI 5K08CA169485-03 Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W CHAPUIS, AUDE FRED HUTCHINSON CANCER RESEARCH CENTER WA $171,372
Gene Therapy Clinical Trials 2015 NCI 5P01CA066726-18 5805 Clinical Trials in Mesothelioma STERMAN, DANIEL UNIVERSITY OF PENNSYLVANIA PA $302,808
Gene Therapy Clinical Trials 2015 NCI 5P01CA066726-18 5808 Administration ALBELDA, STEVEN UNIVERSITY OF PENNSYLVANIA PA $130,455
Gene Therapy Clinical Trials 2015 NCI 5P01CA066726-18 5809 Tissue Acquisition, Processing, and Pathology (TAPP) Core KALOS, MICHAEL UNIVERSITY OF PENNSYLVANIA PA $132,380
Gene Therapy Clinical Trials 2015 NCI 5P01CA066726-18 5810 Biostatistics & Data Management HEITJAN, DANIEL UNIVERSITY OF PENNSYLVANIA PA $97,246
Gene Therapy Clinical Trials 2015 NCI 5R01CA158318-05 mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $347,118
Gene Therapy Clinical Trials 2015 NCI 5P01CA023766-36 6334 Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to O'REILLY, RICHARD SLOAN-KETTERING INST CAN RESEARCH NY $433,106
Gene Therapy Clinical Trials 2015 NCI 5K23CA159391-04 Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus PEIKERT, TOBIAS MAYO CLINIC ROCHESTER MN $164,160
Gene Therapy Clinical Trials 2015 NEI 5R24EY022023-03 rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies HAUSWIRTH, WILLIAM UNIVERSITY OF FLORIDA FL $1,298,215
Gene Therapy Clinical Trials 2015 NIAID 1U19AI117950-01 5400 A PHASE I STUDY OF C34-CXCR4 MODIFIED CD4 T CELLS IN HIV-1 INFECTED INDIVIDUALS TEBAS, PABLO UNIVERSITY OF PENNSYLVANIA PA $576,249
Gene Therapy Clinical Trials 2015 NCI 5P50CA107399-10 5359 Biologics Manufacturing Core COLCHER, DAVID CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $216,379
Gene Therapy Clinical Trials 2015 NCI 5P50CA127001-08 7297 Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors FUEYO, JUAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $295,133
Gene Therapy Clinical Trials 2015 NCI 5P50CA126752-09 0002 CHIMERIC T CELL ANTIGENS TARGETING IG KAPPA LIGHT CHAIN IN B CELL LYMPHOMA DOTTI, GIANPIETRO BAYLOR COLLEGE OF MEDICINE TX $222,662
Gene Therapy Clinical Trials 2015 NCI 5P50CA126752-09 9003 Cell and Vector Production GEE, ADRIAN BAYLOR COLLEGE OF MEDICINE TX $265,039
Gene Therapy Clinical Trials 2015 NCI 5P01CA154778-05 5828 CLINICAL TRIALS USING TCR TRANSDUCED T CELL FOR ADOPTIVE IMMUNOTHERAPY NISHIMURA, MICHAEL LOYOLA UNIVERSITY CHICAGO IL $768,601
Gene Therapy Clinical Trials 2015 NCI 5P01CA148600-05 5308 GMP Cell Therapy and Vector Core GEE, ADRIAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $580,597
Gene Therapy Clinical Trials 2015 NCI 1ZIABC010945-08 Clinical trials employing cancer vaccine combination therapies GULLEY, JAMES NIH $324,191
Gene Therapy Clinical Trials 2015 NCI 1ZIABC010985-08 Gene therapy of cancer ROSENBERG, STEVEN NIH $2,411,384
Gene Therapy Clinical Trials 2015 NCI 1ZIABC011413-05 Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor KOCHENDERFER, JAMES NIH $50,565
Gene Therapy Clinical Trials 2015 NCI 1ZIABC011479-03 T-cell receptor gene therapy for human papillomavirus-positive cancers HINRICHS, CHRISTIAN NIH $664,454
Gene Therapy Clinical Trials 2015 NCI 1ZIABC011498-03 Clinical Trials of Immunotherapies for Childhood Cancer MACKALL, CRYSTAL NIH $1,047,388
Gene Therapy Clinical Trials 2015 NCI 1ZIASC004020-38 Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS BERZOFSKY, JAY NIH $3,304,387
Gene Therapy Clinical Trials 2015 NIAID 1ZIAAI000991-09 Gene Therapy Clinical Trials for Chronic Granulomatous Disease KANG, ELIZABETH NIH $465,906
Gene Therapy Clinical Trials 2015 NIAID 1ZIAAI000992-09 Gene Therapy Clinical Trials for X-linked Severe Combined Immunodeficiency DE RAVIN, SUK NIH $310,604
Gene Therapy Clinical Trials 2015 NHLBI 268201200002I-0-26800005-1 IGF::OT::IGF - GTRP CLINICAL COORDINATING CENTER; TO.5; TASK AREA B; CLINICAL TRIALS; FY15; CAN 8470187; AMT $2,800,040. SEPELAK, SUE SOCIAL AND SCIENTIFIC SYSTEMS, INC. MD $2,800,040


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer